Weight Loss, Weight Maintenance, and Improved Cardiovascular Risk Factors after 2 Years Treatment with Orlistat for Obesity

2000479 citationsJournal Articlebronze Open Access

Authors

Stephan Rössner · Integrated Cardio Metabolic Centre

Lars Sjöström · Sahlgrenska University Hospital

R. Noack

A. Edo Meinders · Leiden University Medical Center

G Noseda · Integrated Cardio Metabolic Centre

on behalf of the European Orlistat Obesity Study

Abstract

Orlistat administered for 2 years promotes weight loss and minimizes weight regain. Additionally, orlistat therapy improves lipid profile, blood pressure, and quality of life.

Topics & Keywords

Pharmacology and Obesity Treatment Obesity and Health Practices Muscle metabolism and nutrition

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Obesity Research

Volume 8, Issue 1, pp. 49-61

DOI: 10.1038/oby.2000.8

Field-Weighted Citation Impact: 22.37